Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Neumann

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Science (New York, N.Y.)|March 28, 2015
Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primatesAndrea Marzi, Peter Halfmann, Lindsay Hill-Batorski, et al.
Journal of Virology|February 13, 2009
Replication-deficient ebolavirus as a vaccine candidatePeter Halfmann, Hideki Ebihara, Andrea Marzi, et al.
Plos Pathogens|July 20, 2006
Molecular determinants of Ebola virus virulence in miceHideki Ebihara, Ayato Takada, Darwyn Kobasa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 11, 2019
A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal InfluenzaAnthony T DiPiazza, Shufang Fan, Ajitanuj Rattan, et al.
Cell Host & Microbe|March 11, 2008
Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transportSeiya Yamayoshi, Takeshi Noda, Hideki Ebihara, et al.
Journal of Virology|December 8, 2017
Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse VirulenceGongxun Zhong, Mai Quynh Le, Tiago J S Lopes, et al.
Scientific Reports|January 28, 2015
Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hostsSeiya Yamayoshi, Satoshi Fukuyama, Shinya Yamada, et al.
Ebiomedicine|February 26, 2024
Characterization of a human H3N8 influenza virusChunyang Gu, Shufang Fan, Randall Dahn, et al.
The Journal of Infectious Diseases|November 30, 2017
Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza VirusMaki Kiso, Tiago J S Lopes, Seiya Yamayoshi, et al.
Vaccines|June 28, 2023
Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 VariantsMichael J Moser, Lindsay Hill-Batorski, Richard A Bowen, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Science (New York, N.Y.)|March 28, 2015
Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primatesAndrea Marzi, Peter Halfmann, Lindsay Hill-Batorski, et al.
Journal of Virology|February 13, 2009
Replication-deficient ebolavirus as a vaccine candidatePeter Halfmann, Hideki Ebihara, Andrea Marzi, et al.
Plos Pathogens|July 20, 2006
Molecular determinants of Ebola virus virulence in miceHideki Ebihara, Ayato Takada, Darwyn Kobasa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 11, 2019
A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal InfluenzaAnthony T DiPiazza, Shufang Fan, Ajitanuj Rattan, et al.
Cell Host & Microbe|March 11, 2008
Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transportSeiya Yamayoshi, Takeshi Noda, Hideki Ebihara, et al.
Journal of Virology|December 8, 2017
Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse VirulenceGongxun Zhong, Mai Quynh Le, Tiago J S Lopes, et al.
Scientific Reports|January 28, 2015
Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hostsSeiya Yamayoshi, Satoshi Fukuyama, Shinya Yamada, et al.
Ebiomedicine|February 26, 2024
Characterization of a human H3N8 influenza virusChunyang Gu, Shufang Fan, Randall Dahn, et al.
The Journal of Infectious Diseases|November 30, 2017
Combination Therapy With Neuraminidase and Polymerase Inhibitors in Nude Mice Infected With Influenza VirusMaki Kiso, Tiago J S Lopes, Seiya Yamayoshi, et al.
Vaccines|June 28, 2023
Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 VariantsMichael J Moser, Lindsay Hill-Batorski, Richard A Bowen, et al.
Pageof 19